Recurrent Breast Cancer Completed Phase 2 Trials for Pazopanib (DB06589)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00509587Pazopanib in Treating Patients With Recurrent or Metastatic Breast CancerTreatment